Literature DB >> 2121091

Motor neuron disease in a patient with a monoclonal IgMk directed against GM1, GD1b, and high-molecular-weight neural-specific glycoproteins.

E Nobile-Orazio1, G Legname, R Daverio, M Carpo, A Giuliani, S Sonnino, G Scarlato.   

Abstract

In a patient with motor neuron disease and benign IgMk monoclonal gammopathy, the M protein reacted with the glycolipids GM1, GD1b, and asialo GM1 and, by immunoblot, with some high-molecular-weight neural-specific glycoproteins. The main reactive bands had an approximate molecular weight of 250 and 400 kd, were most concentrated in the spinal cord, and were also bound by the lectin peanut agglutinin. The presence of the Ga1(beta 1-3)Ga1NAc epitope on these neural-specific glycoproteins may help to explain the selective neurological impairment of the patient.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2121091     DOI: 10.1002/ana.410280215

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  10 in total

Review 1.  Monoclonal IgM autoantibody reactivity in M-IgM peripheral neuropathy.

Authors:  C Caudie
Journal:  Clin Rev Allergy Immunol       Date:  2000-08       Impact factor: 8.667

2.  Structure of the main ganglioside from the brain of Xenopus laevis.

Authors:  Angela Maria Rizzo; Bruno Berra; Federica Rossi; Anna Guerra; Rosalba Gornati; Giovanni Bernardini; Takao Taki; Takeshi Kasama; Laura Mauri; Sandro Sonnino
Journal:  Glycoconj J       Date:  2002-01       Impact factor: 2.916

Review 3.  Multifocal motor neuropathy.

Authors:  E Nobile-Orazio
Journal:  J Neurol Neurosurg Psychiatry       Date:  1996-06       Impact factor: 10.154

4.  Gangliosides and neurological diseases.

Authors:  G Doria; G Tettamanti
Journal:  BMJ       Date:  1993-01-16

Review 5.  Serum Antibodies to Glycans in Peripheral Neuropathies.

Authors:  Sandro Sonnino; Elena Chiricozzi; Maria Grazia Ciampa; Laura Mauri; Alessandro Prinetti; Gino Toffano; Massimo Aureli
Journal:  Mol Neurobiol       Date:  2016-02-11       Impact factor: 5.590

6.  Motor conduction block and high titres of anti-GM1 ganglioside antibodies: pathological evidence of a motor neuropathy in a patient with lower motor neuron syndrome.

Authors:  D Adams; T Kuntzer; A J Steck; A Lobrinus; R C Janzer; F Regli
Journal:  J Neurol Neurosurg Psychiatry       Date:  1993-09       Impact factor: 10.154

7.  Changes of the ganglioside pattern and content in human fibroblasts by high density cell population subculture progression.

Authors:  Mariateresa Sciannamblo; Vanna Chigorno; Alberto Passi; Rea Valaperta; Ileana Zucchi; Sandro Sonnino
Journal:  Glycoconj J       Date:  2002-03       Impact factor: 2.916

8.  The anti-oligosaccharide antibodies present in sera from patients with motor neuron disease and neuropathy recognize the N-glycolylneuraminic acid containing gangliotetrahexosyl oligosaccharide.

Authors:  M Carpo; E Nobile-Orazio; V Chigorno; S Sonnino
Journal:  Glycoconj J       Date:  1995-10       Impact factor: 2.916

Review 9.  Gangliosides. Their role in clinical neurology.

Authors:  E Nobile-Orazio; M Carpo; G Scarlato
Journal:  Drugs       Date:  1994-04       Impact factor: 9.546

10.  Ganglioside antibodies: a lack of diagnostic specificity and clinical utility?

Authors:  M Weller; A Stevens; N Sommer; J Dichgans; B Kappler; H Wiethölter
Journal:  J Neurol       Date:  1992-10       Impact factor: 4.849

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.